Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
DOD awards $16 million to fund development of novel antibiotic
The Defense Threat Reduction Agency, a division of the US Department of Defense, has awarded up to $16 million to VenatoRx Pharmaceuticals for discovery and development of a novel, first-in-class antibiotic for biodefense applications.